HCA Healthcare, Inc. (NYSE:HCA - Get Free Report) SVP Kathryn A. Torres sold 973 shares of the business's stock in a transaction that occurred on Thursday, May 2nd. The stock was sold at an average price of $312.00, for a total value of $303,576.00. Following the completion of the sale, the senior vice president now directly owns 22,365 shares in the company, valued at $6,977,880. The sale was disclosed in a legal filing with the SEC, which can be accessed through this link.
HCA Healthcare Trading Up 0.7 %
Shares of HCA stock opened at $310.06 on Tuesday. The company has a debt-to-equity ratio of 29.26, a quick ratio of 1.02 and a current ratio of 1.16. HCA Healthcare, Inc. has a 52-week low of $215.96 and a 52-week high of $335.83. The stock has a fifty day simple moving average of $321.84 and a two-hundred day simple moving average of $298.27. The firm has a market capitalization of $81.21 billion, a PE ratio of 15.46, a PEG ratio of 1.44 and a beta of 1.66.
HCA Healthcare (NYSE:HCA - Get Free Report) last released its quarterly earnings data on Friday, April 26th. The company reported $5.36 earnings per share (EPS) for the quarter, beating the consensus estimate of $5.01 by $0.35. The firm had revenue of $17.34 billion for the quarter, compared to analysts' expectations of $16.81 billion. HCA Healthcare had a net margin of 8.20% and a return on equity of 674.49%. The company's revenue for the quarter was up 11.2% compared to the same quarter last year. During the same quarter last year, the business posted $4.93 earnings per share. On average, analysts predict that HCA Healthcare, Inc. will post 20.74 EPS for the current fiscal year.
Urgent Nvidia Warning
From Altimetry | Ad
Could Steve Job's 'Final Prophecy' Make You Rich?
Just before he died, Steve Jobs issued a "Final Prophecy" that's now coming true... and making some people rich. In one recent 90-day stretch, 50 companies related to Jobs' "Final Prophecy" soared by 100% or more. What was Steve Jobs' last big prediction, and how can you get in on it? Professor Joel Litman explains everything... including the surprising group of stocks moving higher, and his No. 1 favorite stock in this space.
Click here to access…
HCA Healthcare declared that its board has authorized a share repurchase plan on Tuesday, January 30th that allows the company to repurchase $6.00 billion in shares. This repurchase authorization allows the company to purchase up to 7.4% of its shares through open market purchases. Shares repurchase plans are typically an indication that the company's board believes its stock is undervalued.
HCA Healthcare Announces Dividend
The company also recently disclosed a quarterly dividend, which will be paid on Friday, June 28th. Shareholders of record on Friday, June 14th will be paid a $0.66 dividend. This represents a $2.64 dividend on an annualized basis and a yield of 0.85%. The ex-dividend date is Friday, June 14th. HCA Healthcare's payout ratio is 13.16%.
Wall Street Analyst Weigh In
Several equities analysts recently issued reports on the company. Barclays upped their price objective on HCA Healthcare from $356.00 to $367.00 and gave the company an "overweight" rating in a research report on Monday, April 29th. Deutsche Bank Aktiengesellschaft upped their price objective on HCA Healthcare from $330.00 to $359.00 and gave the company a "buy" rating in a research report on Friday, April 12th. Truist Financial upped their price objective on HCA Healthcare from $320.00 to $345.00 and gave the company a "buy" rating in a research report on Wednesday, January 31st. TD Cowen decreased their target price on shares of HCA Healthcare from $371.00 to $360.00 and set a "buy" rating for the company in a research note on Tuesday, April 30th. Finally, StockNews.com raised HCA Healthcare from a "buy" rating to a "strong-buy" rating in a report on Thursday, May 2nd. Four analysts have rated the stock with a hold rating, twelve have given a buy rating and one has assigned a strong buy rating to the stock. Based on data from MarketBeat.com, HCA Healthcare currently has a consensus rating of "Moderate Buy" and a consensus price target of $316.59.
View Our Latest Stock Report on HCA Healthcare
Hedge Funds Weigh In On HCA Healthcare
Institutional investors have recently bought and sold shares of the business. Stone House Investment Management LLC bought a new stake in shares of HCA Healthcare in the 3rd quarter worth about $25,000. Centerpoint Advisors LLC bought a new stake in shares of HCA Healthcare in the 4th quarter worth about $27,000. Atlantic Edge Private Wealth Management LLC bought a new stake in shares of HCA Healthcare in the 4th quarter worth about $27,000. LifeSteps Financial Inc. bought a new position in HCA Healthcare during the 1st quarter valued at about $33,000. Finally, Bruce G. Allen Investments LLC bought a new position in HCA Healthcare during the 4th quarter valued at about $28,000. Institutional investors own 62.73% of the company's stock.
HCA Healthcare Company Profile
(
Get Free Report)
HCA Healthcare, Inc, through its subsidiaries, owns and operates hospitals and related healthcare entities in the United States. It operates general and acute care hospitals that offers medical and surgical services, including inpatient care, intensive care, cardiac care, diagnostic, and emergency services; and outpatient services, such as outpatient surgery, laboratory, radiology, respiratory therapy, cardiology, and physical therapy.
Read More
This instant news alert was generated by narrative science technology and financial data from InsiderTrades.com in order to provide readers with the fastest and most accurate reporting. This story was reviewed by InsiderTrades.com's editorial team prior to publication. Please send any questions or comments about this story to [email protected].
